Page 1,174«..1020..1,1731,1741,1751,176..1,1801,190..»

Lot 15. Hannafords Stud Skipolena- Auctions Plus Progressive Genetics Sale – Video


Lot 15. Hannafords Stud Skipolena- Auctions Plus Progressive Genetics Sale
Lot 15 Hannafords Stud Skipolena- Auctions Plus Progressive Genetics Sale This mare had a cut on her forearm which left a scar and an indentation in the muscle. Skipolena #39;s dam got round money at her only appearance at Warwick. This family of horses are super trainable and athletic. Skipolena is being offered with a filly foal at foot by One Moore Daddy AQHA Q-54632, giving the foal a double cross of the great One Moore Spin. More Information: localmedia.auctionsplus.com.au http://www.landmark-classic.com.au Sale on Auctions Plus 10th December 2012From:LandmarkEquineViews:0 0ratingsTime:00:47More inSports

See the original post:
Lot 15. Hannafords Stud Skipolena- Auctions Plus Progressive Genetics Sale - Video

Recommendation and review posted by Bethany Smith

little mix DNA – Video


little mix DNA
tumblr: onedirectionslittlemixer.tumblr.com twitter: twitter.com feel free to request anything! LYRICS: Perrie: Does he tell you he love you when you least expect it? Does he flutter your heart when he kisses your neck? no scientist or biology its obvious when hes holding me its only natural that im so affected Jade: Ohh and my heaert wont beat again if i cant feel him in my veins no need to question i already know All: its in his DNA DDD DNA its in his DNA and he just take my breath away BBB-Breath away i see it in his face and thats what makes a man not hard to understand perfect in every way i see it in his face nothing more to say its in his DDDD-DNA Jesy: Its the blue in his eyes that helps me see the future fingerprints that leave me covered for days yeah hey yeah now i dont have any 1st degree but i know what he does to me no need to work it out its so familiar ohhhh oh oh Jade: and my heart wont beat again if i cant feel him in my veins no need to question i already know All: iits in his DNA DDDDNA its in his DNA and he just takes my Breath away BBBBreath away i see it in his face and thats what makes a man not hard to understand perfect in every way i see it in his face nothing more to say its in his DDDDDNA Leigh Ann: Its all about his kiss contaminates my lips our energy connects its simple genetics im the x to his y its the color of his eyes he can do no wrong no he dont need to try made from the best he passes all the test got my hear beating fast its cardiac ...From:OneDirection9500Views:1 0ratingsTime:04:01More inMusic

Link:
little mix DNA - Video

Recommendation and review posted by Bethany Smith

BIMS 320 Epigenetics Movie – Video


BIMS 320 Epigenetics Movie
BIMS 320 Epigenetic Group Project By: Texas A M Students Thank you to: http://www.youtube.com for the 18 things about Genetics portionFrom:Megan BrinkmanViews:1 0ratingsTime:12:59More inScience Technology

See the rest here:
BIMS 320 Epigenetics Movie - Video

Recommendation and review posted by Bethany Smith

Learning to read Palms – Video


Learning to read Palms
I will continue to research the topic of chiromancy. Please share your thoughts and what you know about this topic in the comments below. 4:00 I begin to read (the book). The phrase "the future is in your hands" may begin to mean more to you than you previously thought. Nowadays the practice of chiromancy is widely used by specialists in the field of genetics and psychiatry as one of the additional methods of diagnostics. " It would seem that from the very beginning there were two traditions. The first linked chiromancy closely with astrology and so produced a quasi-systematic framework for its references and predictions. The second was not connected with astrology at all, but with intuition, whose methodological principles are not clear. In the Middle Ages the Christian chiromantics found a scriptural basis for chiromancy in Job 37:7: "He sealeth up the hand of every man, that all men may know his work" which could be interpreted to mean that the hand imprints are made by God for the purpose of chiromancy." When you know yourself you are better able to . . . 9:55 predestination and free will are not imcompatible Our destiny is in our hands. 11:30 A study of palmistry can make us more optimistic Preparing to read your palm. 12:20 we chage our destiny when we change ourselves Palmistry can be used as a pleasant party past time. When you begin to study hands you begin to gain insight about the people around you. Studying the hands of a person can lead to increased intimacy ...From:marcus86edViews:1 0ratingsTime:23:34More inPeople Blogs

The rest is here:
Learning to read Palms - Video

Recommendation and review posted by Bethany Smith

Genetics basic – Video


Genetics basic
Science - Year 10 - Genetics Q1From:ProblemSolving PenguariumViews:0 0ratingsTime:02:01More inEducation

Continue reading here:
Genetics basic - Video

Recommendation and review posted by Bethany Smith

Lot 21. Hannafords Crown Prince- Auctions Plus Progressive Genetics Sale – Video


Lot 21. Hannafords Crown Prince- Auctions Plus Progressive Genetics Sale
Lot 21. Hannafords Crown Prince- Auctions Plus Progressive Genetics Sale This colt is the real deal. He has the looks and the breeding, his dam is by Acres Destiny, out of Tassas Robin Hood #39;s dam. Destinys Gold Dust is a full sister to Cal Gibson #39;s mare who finalled at Warwick, as well as being a full sister in blood in Serene Acres More Information: localmedia.auctionsplus.com.au http://www.landmark-classic.com.au Sale on Auctions Plus 10th December 2012From:LandmarkEquineViews:0 0ratingsTime:00:46More inSports

Originally posted here:
Lot 21. Hannafords Crown Prince- Auctions Plus Progressive Genetics Sale - Video

Recommendation and review posted by Bethany Smith

Lot 18. Hannaford Forever Babe – Auctions Plus Progressive Genetics Sale – Video


Lot 18. Hannaford Forever Babe - Auctions Plus Progressive Genetics Sale
Lot 18. Hannaford Forever Babe - Auctions Plus Progressive Genetics Sale Beautiful temperament and body type, typical of her deceased sire. Has bred some beautiful foals for us. Will have a foal by sale time to Hannafords Chief Justice AQHA Q-74413, ASHS C2-199215. who is by Acres Destiny. More Information: localmedia.auctionsplus.com.au http://www.landmark-classic.com.au Sale on Auctions Plus 10th December 2012From:LandmarkEquineViews:3 0ratingsTime:00:57More inSports

See more here:
Lot 18. Hannaford Forever Babe - Auctions Plus Progressive Genetics Sale - Video

Recommendation and review posted by Bethany Smith

The Angus Report, Dec. 3, 2012: Performance Insights – Video


The Angus Report, Dec. 3, 2012: Performance Insights
What is an EPD? Angus Genetics Inc. #39;s Tonya Amen gives you the no-nonsense explanation.From:apicreativemediaViews:2 0ratingsTime:02:04More inPets Animals

Read the original:
The Angus Report, Dec. 3, 2012: Performance Insights - Video

Recommendation and review posted by Bethany Smith

THE MIRACLE OF EVOLUTION – Video


THE MIRACLE OF EVOLUTION
The word "evolution" is an accordion-word that can be expanded or contracted to suit the occasion. The evolutionary biologist Francisco Ayala points out that the word "evolution" can be used to mean at least three different things: 1. The process of change and diversification of living things over time. It is in this sense that biologists say that evolution is a fact. But obviously this fact, so stated, is innocuous and would not be disputed even by the most fundamentalist Young Earth Creationist. 2. Reconstruction of evolutionary history, showing how various lineages branched off from one another on the universal tree of life. 3. The mechanisms which account for evolutionary change. Darwin appealed to natural selection operating on random variations in living things in order to explain the adaptedness of organisms to their environment. With the development of modern genetics, genetic mutations came to supplement the Darwinian mechanism of natural selection by supplying an explanation for the variations on which natural selection works. Accordingly, we can call this hypothesis "neo-Darwinism." Evolution in the senses of (2) and (3) is not an established fact, despite what is said and believed in popular culture. According to Ayala, "The second and third issues mdash;seeking to ascertain evolutionary history as well as to explain how and why evolution takes place mdash;are matters of active scientific investigation. To reconstruct evolutionary history, we have to know how the ...From:POTTERS HOUSE CHRISTIAN FELLOWSHIP CHRISTCHURCHViews:2 0ratingsTime:01:56More inTravel Events

Read this article:
THE MIRACLE OF EVOLUTION - Video

Recommendation and review posted by Bethany Smith

Celebrating IR100k at IRRI! – Video


Celebrating IR100k at IRRI!
Also see playlist of other videos from this ceremony at http://www.youtube.com On 29 November 2012, the IRRI community celebrated the100,000th rice breeding cross at IRRI, a true milestone in the Institute #39;s 52-year history existence. The parents for the 100000th cross were IR09M105 and NSICRC 214.The objective of this particular cross was to improve eating quality. Making opening comments at the event were Eero Nissila, head of Plant Breeding, Genetics and Biotechnology at IRRI -www.irri.org - and Glenn Gregorio, senior scientist/plant breeder - http://www.irri.org Alvaro Pamplona, senior research manager, demonstrates how the 100000th cross was made--as are all crosses at IRRI--for more on how the cross is made, see http://www.youtube.com Bas Bouman (right) director of the Global Rice Science Partnership (GRiSP) and Bruce Tolentino, deputy director general for communications and partnerships, "lift" the ribbon at the display showing the mature plants resulting from the cross along with the parents in the background.From:irrivideoViews:3 0ratingsTime:02:06More inEducation

Original post:
Celebrating IR100k at IRRI! - Video

Recommendation and review posted by Bethany Smith

Supreme Court of the United States to Hear Isolated DNA Patent Case

SALT LAKE CITY, Nov. 30, 2012 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (MYGN) reported today that the Supreme Court of the United States granted certiorari agreeing to hear the case of The Association for Molecular Pathology, et al., v. Myriad Genetics, Inc., et al (Docket No. 12-398). The Supreme Court will review the earlier decision by the U.S. Court of Appeals for the Federal Circuit, which declared that Myriad's composition of matter claims covering isolated DNA of the BRCA 1 and BRCA 2 genes are patent-eligible under Section 101 of the United States Patent Act.

"Two previous decisions by the Federal Circuit Court of Appeals confirmed the patentability of our groundbreaking diagnostic test that has helped close to one million people learn about their hereditary cancer risk," said Peter Meldrum, President and CEO of Myriad Genetics. "Myriad devoted more than 17 years and $500 million to develop its BRACAnalysis(R) test. The discovery and development of pioneering diagnostics and therapeutics require a huge investment and our U.S. patent system is the engine that drives this innovation. This case has great importance for the hundreds of millions of patients whose lives are saved and enhanced by the life science industry's products."

About Genetic Patents and Genetic Testing

The BRACAnalysis test detects the presence of the BRCA1 and BRCA2 genetic mutations that can help determine a patient's risk of breast and ovarian cancer and inform treatment options. Women who test positive using Myriad's BRACAnalysis have an 82 percent higher risk of developing breast cancer and a 44 percent higher risk of ovarian cancer in their lifetimes. The test is widely available for all women with a family history of cancer and is cost effective for both patients and the healthcare system. Approximately one million women have already benefited from taking the BRACAnalysis test.

Myriad supports research studies on BRCA1, BRCA2 and other genes. More than 18,000 scientists have studied the BRCAgenes and published more than 9,000 research papers, making these genes among the most widely researched genes in history. In addition, Myriad has facilitated research through a partnership with the National Institutes of Health and provided at-cost testing for nearly 6,000 researchers receiving NIH grants.

Health economic studies conclude that Myriad's genetic tests are fairly priced. Excerpts supporting this conclusion include the following:

Additionally, Myriad has also established a Financial Assistance Program, which provides coverage at no charge to low-income patients who lack insurance. Over the past three years alone, more than 5,000 people have received free BRACAnalysis testing from Myriad. Approximately 95% of all patients in the United States have access to BRACAnalysis either through private insurance, Medicare or Medicaid. The average out-of-pocket cost to a patient is less than $100.

Even though Myriad automatically retests all positive results to confirm the findings at no additional charge to the patient, second-opinion testing is also available for all patients. Since 1999, many laboratories have performed confirmatory and second-opinion testing. The NCBI Genetic Testing Registry lists seven laboratories in the United States that conduct second-opinion testing on the BRCA 1 gene and six laboratories that test the BRCA 2 gene.

About Myriad's Patent Landscape

Myriad's intellectual property for its BRACAnalysis(R) test is strong, with 24 issued patents and more than 500 claims. This provides Myriad with extensive patent protection through 2018.

Read more from the original source:
Supreme Court of the United States to Hear Isolated DNA Patent Case

Recommendation and review posted by Bethany Smith

Scott C. Baraban, PhD discusses the current trend in epilepsy research – Video


Scott C. Baraban, PhD discusses the current trend in epilepsy research
Dr. Scott Baraban, PhD, a Professor and William K. Bowes Endowed Chair in Neuroscience Research at the University of California, San Francisco, discusses the current trends of epilepsy research and the future direction of epilepsy care, particularly noting the role of gene therapy in management. This video was taken on Friday, November 30th at the American Epilepsy Society #39;s 2012 Annual Meeting in San Diego, CA.From:AJMCtvViews:5 0ratingsTime:00:59More inEducation

Read the rest here:
Scott C. Baraban, PhD discusses the current trend in epilepsy research - Video

Recommendation and review posted by Bethany Smith

Personalized medicine to save lung cancer patients – Video


Personalized medicine to save lung cancer patients
This video focuses on Ventana Medical Systems collaboration with Pfizer to save lung cancer patients. This segment is part of a series featuring Ventana Medical Systems luminaries, created to raise awareness of Ventana #39;s innovative work in cancer over the past 25 years and expectations for the future.From:VentanaMarcomViews:7 0ratingsTime:02:00More inScience Technology

Excerpt from:
Personalized medicine to save lung cancer patients - Video

Recommendation and review posted by sam

Four Different Types of Biomarkers – Video


Four Different Types of Biomarkers
Daniel Winkelman from BioTrends defines the different types of biomarkers at the HBAGP event, "An Overview of Personalized Medicine Future Opportunities" held at Merck on November 29, 2012From:HBAGPViews:0 0ratingsTime:00:55More inEducation

View post:
Four Different Types of Biomarkers - Video

Recommendation and review posted by sam

Personalized Medicine Definition – Video


Personalized Medicine Definition
Daniel Winkelman from BioTrends at the Healthcare Businesswomen #39;s Association Greater Philadelphia chapter event "Personalized Medicine Future Opportunities." Held at Merck, the seminar was presented by the HBAGP Women In Science affinity group.From:HBAGPViews:2 0ratingsTime:00:18More inEducation

See the rest here:
Personalized Medicine Definition - Video

Recommendation and review posted by sam

Voluntary Motor Function and Spasticity After A Spinal Cord Injury PodChat – Video


Voluntary Motor Function and Spasticity After A Spinal Cord Injury PodChat
Molly addresses the question about how long after injury she was able to move voluntarily. This conversation addresses her relationship to spasticity and the anti-spasmodic drug Baclofen.From:abilityproductionViews:25 1ratingsTime:07:38More inEducation

See original here:
Voluntary Motor Function and Spasticity After A Spinal Cord Injury PodChat - Video

Recommendation and review posted by sam

RICKY HONABLUE – Spinal Cord Injury – Video


RICKY HONABLUE - Spinal Cord Injury
When a car jumped the sidewalk and hit 2-year-old Ricky Honablue head on, his mother #39;s world was shattered in an instant. Ricky suffered a severe spinal cord injury and was paralyzed from the chest down. A few years after the accident, the Honablue family moved to Michigan. Ricky receives weekly physical therapy at the Children #39;s Hospital of Michigan and is actually walking using a special brace called an RGO (Reciprocating Gait Orthosis.) While his wheelchair is still his most convenient mode of transportation, the ability to walk gives Ricky a sense of freedom and joy that can only come from standing on your own two feet.From:ChildrensDMCViews:1 0ratingsTime:07:22More inEducation

Originally posted here:
RICKY HONABLUE - Spinal Cord Injury - Video

Recommendation and review posted by sam

“Spinal Cord Injury in Nepal and Challenges in Rehabilitation” – Damodar Thapa, PT – Video


"Spinal Cord Injury in Nepal and Challenges in Rehabilitation" - Damodar Thapa, PT
Mr. Thapa shares some of the unique challenges faced by survivors of SCI in his homeland of Nepal. His words and pictures illustrate the tools and techniques he uses to maximize recovery in his patients.From:unite2fightparalysisViews:0 0ratingsTime:11:35More inNonprofits Activism

Follow this link:
"Spinal Cord Injury in Nepal and Challenges in Rehabilitation" - Damodar Thapa, PT - Video

Recommendation and review posted by sam

Quadriplegic opening easy-open cans – Video


Quadriplegic opening easy-open cans
Watch how SPINALpedia member and C6-7 quadriplegic, Paul, demonstrates how he opens easy-open cans without the use of his fingers (but with the help of a spoon!) Even if you #39;re paralyzed from a spinal cord injury, you can find ways to adapt normal tasks. Learn more at SPINALpedia.com!From:Spinal PediaViews:3 0ratingsTime:02:06More inHowto Style

Read the rest here:
Quadriplegic opening easy-open cans - Video

Recommendation and review posted by sam

“Fountain of Youth” technique rejuvenates aging stem cells – Study moves scientists one step closer to creating …

Study moves scientists one step closer to creating youthful heart patches from old cells

TORONTO, ON A new method of growing cardiac tissue is teaching old stem cells new tricks. The discovery, which transforms aged stem cells into cells that function like much younger ones, may one day enable scientists to grow cardiac patches for damaged or diseased hearts from a patients own stem cellsno matter what age the patientwhile avoiding the threat of rejection.

Stem cell therapies involving donated bone marrow stem cells run the risk of patient rejection in a portion of the population, argues Milica Radisic, Canada Research Chair in Functional Cardiovascular Tissue Engineering at the Institute of Biomaterials and Biomedical Engineering (IBBME) and Associate Professor in the Department of Chemical Engineering and Applied Chemistry at the University of Toronto.

One method of avoiding the risk of rejection has been to use cells derived from a patients own body. But until now, clinical trials of this kind of therapy using elderly patients own cells have not been a viable option, since aged cells tend not to function as well as cells from young patients.

Its a problem that Radisic and her co-researcher, Dr. Ren-Ke Li, think they might have an answer for: by creating the conditions for a fountain of youth reaction within a tissue culture.

Li holds the Canada Research Chair in Cardiac Regeneration and is a Professor in the Division of Cardiovascular Surgery, cross-appointed to IBBME. He is also a Senior Scientist at the Toronto General Research Institute.

Radisic and Li first create a micro-environment that allows heart tissue to grow, with stem cells donated from elderly patients at the Toronto General Hospital.

The cell cultures are then infused with a combination of growth factorscommon factors that cause blood vessel growth and cell proliferationpositioned in such a way within the porous scaffolding that the cells are able to be stimulated by these factors.

Dr. Li and his team then tracked the molecular changes in the tissue patch cells.

We saw certain aging factors turned off, states Li, citing the levels of two molecules in particular, p16 and RGN, which effectively turned back the clock in the cells, returning them to robust and healthy states.

Follow this link:
“Fountain of Youth” technique rejuvenates aging stem cells - Study moves scientists one step closer to creating ...

Recommendation and review posted by Bethany Smith

Aida Wong – ZÉLL-V Sheep Placenta Anti Aging Satisfied Customer – Video


Aida Wong - ZÉLL-V Sheep Placenta Anti Aging Satisfied Customer
Aida : #25317; #26377; #20581; #24247;= #25317; #26377; #20840; #19990; #30028; #12290; http://www.zell-v.com We specialise in cell therapy products for anti aging. we are supported by an international medical board of practitioners, biologist and wellness professionals.From:zellvsheepplacentaViews:1 0ratingsTime:01:34More inHowto Style

Read more:
Aida Wong - ZÉLL-V Sheep Placenta Anti Aging Satisfied Customer - Video

Recommendation and review posted by Bethany Smith

Metastatic melanoma patient discusses how T-cell therapy saved her life – Video


Metastatic melanoma patient discusses how T-cell therapy saved her life
Nicho Bourque, a metastatic melanoma patient, was the first MD Anderson clinical trial patient to receive a new form of adoptive T-cell therapy, called T-cell therapy with dendritic cells. Learn about her experience with the treatment. Bourque was under the care of Nicholas Papadopoulos, MDFrom:mdandersonorgViews:0 0ratingsTime:04:22More inScience Technology

Here is the original post:
Metastatic melanoma patient discusses how T-cell therapy saved her life - Video

Recommendation and review posted by Bethany Smith

Dr.Farshchian: Achilles Tendinitis is Now Being Treated Using Regenerative Medicine and Cell Therapy

"Achilles Tendinitis is now being treated using Regenerative Medicine and Cell Therapy," according to Dr. Farshchian , the medical director for The Center for Regenerative Medicine.

(PRWEB) November 30, 2012

Achilles tendonitis refers to irritation and inflammation of the Achilles tendon which is located in the back of the ankle. Pain and swelling are typical symptoms, but over the long run the tendon can weaken and rupture this is a serious matter since it may cause chronic pain and disability. Typically patients experience most of the pain during running and jumping.

Changes in footwear and training schedules as reported by the above patient could be a contributory factor to development Achilles tendinitis.

The Center for Regenerative Medicine in Miami, Florida concentrates on helping arthritic and injured people to get back to a functional level of life and their activities using non-surgical techniques and Orthopedic medicine. The center's expertise is in treatment of conditions of spine, knees , shoulders , and other cartilage damages. They have developed non-surgical and rehabilitation techniques focused on treatment and management of joint pain. Their team includes health professionals organized around a central theme.

Their wbsite is http://www.arthritisusa.net

Marty Eugene http://www.arthritisusa.net 305 8668384 Email Information

Originally posted here:
Dr.Farshchian: Achilles Tendinitis is Now Being Treated Using Regenerative Medicine and Cell Therapy

Recommendation and review posted by Bethany Smith

QualityStocks News – International Stem Cell Corp. Advances Groundbreaking Stem Cell Therapy with Distinct Advantages …

Company's ability to do something nobody has done before confirms world-leader status.

Scottsdale, AZ (PRWEB) November 30, 2012

In the companys news yesterday,

International Stem Cell Corp. has achieved a critical milestone towards the clinical development of its non-embryonic stem cell therapy.

Through much dedication and hard work, the companys research and development team has created the worlds first human clinical-grade stem cell lines that can be immune-match to millions of individuals. ISCOs existing research-grade parthenogenetic stem cell lines, one of which may be an immune-match to approximately 70 million people, are being used in pre-clinical development. ISCO is now in a position to conduct clinical trials in the United States.

Weve been working diligently for three years to perfect this technology, which was first developed by our scientific founder, Dr. Elena Revazova in Moscow, and Im excited to report that we have been able to derive new stem cell lines in the United States under the US and California regulatory frameworks. Im optimistic that the new parthenogenetic stem cell lines, by providing a potentially unlimited supply of cells and tissue for transplantation, will be of great benefit to the medical community and patients world-wide, stated Dr. Semechkin, CEO and Co-Chairman of the Board.

Created using ISCOs proprietary technology, the new stem cell lines represent the first of a new generation of clinical-grade human parthenogenetic stem cell (hpSC) lines created in the United States under US regulatory oversight and designed to meet FDA regulations. The US Food and Drug Administration developed Good Tissue Practice (GTP) and Good Manufacturing Practice (GMP) standards to ensure the safety of products developed for clinical use. Conforming to GMP is necessary to conduct clinical development programs.

Independent third-party testing has confirmed the new lines to be homozygous in the HLA coding regions. This means that they have a simple genetic profile in the critical areas of the DNA that code for immune rejection; a distinct clinical advantage over embryonic stem cells. The company anticipates the new lines to immune-match millions of individuals. They will be added to ISCOs existing bank and provide a platform from which to develop cells and tissue for clinical use.

The importance of this breakthrough cannot be overstated, emphasized Dr. Craw, Executive Vice President of ISCO. Expanding our collection is not only important for our therapeutic programs, but also further establishes our leadership position in human stem cell technology. Achieving this critical milestone moves us along the path to make the transition into a clinical stage company.

About QualityStocks

Read more:
QualityStocks News - International Stem Cell Corp. Advances Groundbreaking Stem Cell Therapy with Distinct Advantages ...

Recommendation and review posted by Bethany Smith

International Stem Cell Corporation Announces Significant Progress Towards Clinical Development

CARLSBAD, CA--(Marketwire - Nov 29, 2012) - International Stem Cell Corporation ( OTCQB : ISCO ) (www.internationalstemcell.com) ("ISCO" or "the Company"), a California-based biotechnology company focused on the development of therapeutic products, today announced the achievement of a critical milestone towards the clinical development of its stem cell therapy.

The Company's research and development team has created the world's first human clinical-grade stem cell lines with the ability to immune-match millions of individuals. ISCO's existing research-grade parthenogenetic stem cell lines, one of which contains the most common immune type in the Caucasian population and may be an immune-match to approximately 70 million people, are used in pre-clinical development. These new clinical-grade stem cell lines position ISCO to be able to conduct clinical trials in the United States.

Dr. Semechkin, CEO and Co-Chairman of the Board, comments, "We've been working diligently for three years to perfect this technology, which was first developed by our scientific founder, Dr. Elena Revazova in Moscow, and I'm excited to report that we have been able to derive new stem cell lines in the United States under the US and California regulatory frameworks. I'm optimistic that the new parthenogenetic stem cell lines, by providing a potentially unlimited supply of cells and tissue for transplantation, will be of great benefit to the medical community and patients world-wide."

The new stem cell lines, created using ISCO's proprietary technology, are the first of a new generation of clinical-grade human parthenogenetic stem cell (hpSC) lines created in the United States under US regulatory oversight and designed to meet FDA regulations. The US Food and Drug Administration developed Good Tissue Practice (GTP) and Good Manufacturing Practice (GMP) standards to ensure the safety of products developed for clinical use. Conforming to GMP is extremely important as it means that the cells can be used in clinical development programs.

The new lines have been confirmed by independent third-party testing to be "homozygous" in the HLA coding regions meaning that they have a simple genetic profile in the critical areas of the DNA that code for immune rejection. This feature is one of the most important differences of hpSC when compared with embryonic stem cells and a distinct clinical advantage because of their ability to be immune-matched to the patient. We expect the new lines to immune-match millions of individuals, and will be added to ISCO's existing bank providing a platform from which to develop cells and tissue for clinical use.

"The importance of this breakthrough cannot be overstated," commented Dr. Craw, Executive Vice President of ISCO. "Expanding our collection is not only important for our therapeutic programs, but also further establishes our leadership position in human stem cell technology. Achieving this critical milestone moves us along the path to make the transition into a clinical stage company."

About International Stem Cell Corporation

International Stem Cell Corporation is focused on the therapeutic applications of human parthenogenetic stem cells (hpSCs) and the development and commercialization of cell-based research and cosmetic products. ISCO's core technology, parthenogenesis, results in the creation of pluripotent human stem cells from unfertilized oocytes (eggs) hence avoiding ethical issues associated with the use or destruction of viable human embryos. ISCO scientists have created the first parthenogenetic, homozygous stem cell line that can be a source of therapeutic cells for hundreds of millions of individuals of differing genders, ages and racial background with minimal immune rejection after transplantation. hpSCs offer the potential to create the first true stem cell bank, UniStemCell. ISCO also produces and markets specialized cells and growth media for therapeutic research worldwide through its subsidiary Lifeline Cell Technology (www.lifelinecelltech.com), and stem cell-based skin care products through its subsidiary Lifeline Skin Care (www.lifelineskincare.com). More information is available at http://www.internationalstemcell.com.

To receive ongoing corporate communications via email, visit: http://www.b2i.us/irpass.asp?BzID=1468&to=ea&s=0

To like our Facebook page or follow us on Twitter for company updates and industry related news, visit: http://www.facebook.com/InternationalStemCellCorporation and http://www.twitter.com/intlstemcell

See the rest here:
International Stem Cell Corporation Announces Significant Progress Towards Clinical Development

Recommendation and review posted by Bethany Smith


Archives